Prestige Consumer (NYSE: PBH) awards director 2,981 RSUs worth $155K

Rhea-AI Filing Summary

BYOM JOHN E reported acquisition or exercise transactions in this Form 4 filing.

Prestige Consumer Healthcare Inc. director John E. Byom received a grant of 2,981 restricted stock units, valued at $155,000 based on a $52.00 closing price on August 4, 2026, under the director compensation program. The RSUs vest after one year, and his direct common stock holdings are now 54,575 shares.

Insider Trade Summary

Net Buyer: 2,981 shares

Net Buy 1 txn

Insider BYOM JOHN E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share F1	2,981	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 54,575 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

Key Figures

Restricted stock units granted: 2,981 units Grant value: $155,000 Closing stock price used for award: $52.00 per share +2 more

5 metrics

Restricted stock units granted 2,981 units Equity award to director John E. Byom on August 4, 2026

Grant value $155,000 Value of RSU award under director compensation program

Closing stock price used for award $52.00 per share Prestige Consumer closing price on August 4, 2026

Shares held after transaction 54,575 shares John E. Byom’s direct common stock holdings after the RSU grant

RSU vesting period 1 year Restricted stock units vest on the first anniversary of grant

Key Terms

restricted stock units, director compensation program, change in control

3 terms

restricted stock units financial

"The Reporting Person received 2,981 restricted stock units equal to $155,000..."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

director compensation program financial

"...in connection with the Issuer's director compensation program."

change in control financial

"...promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control."

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/05/2026 - 04:07 PM Accepted by SEC EDGAR 08/05/2026 - 04:06 PM Learn about SEC filing dates

FAQ

What equity award did Prestige Consumer (PBH) director John E. Byom receive?

John E. Byom received 2,981 restricted stock units valued at $155,000. The award was calculated using Prestige Consumer Healthcare’s $52.00 closing stock price on August 4, 2026, as part of the company’s director compensation program.

How was the PBH director stock grant value of $155,000 determined?

The grant value of $155,000 was determined by dividing that amount by Prestige Consumer Healthcare’s $52.00 closing stock price on August 4, 2026, resulting in an award of 2,981 restricted stock units to director John E. Byom.

When do the 2,981 restricted stock units granted by PBH vest?

The 2,981 restricted stock units granted to John E. Byom vest on the first anniversary of the August 4, 2026 grant date. After vesting, they will be settled in shares of Prestige Consumer common stock, subject to specified triggering events.

How will John E. Byom’s PBH restricted stock units be settled?

Each vested restricted stock unit will be settled by delivering one share of Prestige Consumer common stock. Settlement occurs promptly after the earliest of death, separation from service, or a change in control of the company, according to the award terms.

What are John E. Byom’s PBH share holdings after this stock grant?

Following the grant, John E. Byom directly holds 54,575 shares of Prestige Consumer common stock. This figure reflects his position after receiving the 2,981 restricted stock units reported in the August 4, 2026 Form 4 filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BYOM JOHN E

(Last) (First) (Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN NEW YORK 10591

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	08/04/2026		A		2,981(1)	A	$0	54,575	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.

	/s/ John E. Byom by William P'Pool Attorney-in-Fact pursuant to Power of Attorney dated May 8, 2017 on file with the Commission	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)